INTRODUCTION
Since the description of a genetically transmitted defect in the synthesis of the Cl 1 inhibitor by Donaldson and Evans (1), human deficiencies or abnormalities in the function of each of the earlier acting components of complement have been reported (2, 3) . Recently, re- ports have described hereditary deficiencies in man of two of the later acting complement components, the sixth (4) and seventh (5, 6) . The purpose of this report is to describe a hereditary deficiency in the eighth component of complement in a woman with a disseminated gonococcal infection (DGI)' and the possible relationship of this defect to her disseminated infection.
PATIENT HISTORY
A 23-yr-old black women was admitted to the hospital in October 1974, because of progressive polyarthralgia, malaise, and fever of 3i wk duration. Initially, the patient had swelling, pain, and tenderness in the second through fifth metacarpal-phalangeal and proximal interphalangeal joints of her right hand. This persisted for 2-3 days and was associated with fever to 1020F; the symptoms abated with aspirin and bed rest treatment. Subsequently, she again had fever and myalgia with swelling and tenderness of both ankles. 3 days before admission her right knee became swollen and warm. The fever and malaise persisted. At the time of admission the angle and knee pain were severe and the patient could no longer walk without assistance. She did not note skin lesions and did not have a history of previous arthritis, Raynaud's phenomenon, or unusual bleeding.
In 1973, while 7 mo pregnant, the patient had painful swelling of her right arm. Pyuria was found and she was treated with oral ampicillin. A cervical culture done at the time of that examination yielded Neisseria gonorrhoeae. It was not determined if she had DGI.
The patient had previous hospitalizations including two for delivery by cesarean section. An umbilical herniorrhaphy was done at age 1 and a tonsillectomy and adenoidec-'Abbreziations used in this paper: Cd, complement donor serum; CFU, colony-forming unit; CH50, hemolytic whole complement assay; C3PA, C3 proactivator; DGI, dis A blood culture and cervical culture taken at admission were positive for N. gonorrhoeae, confirming the diagnosis of DGI. Therapy was 12 million U of penicillin intravenously per day for 4 days followed by oral ampicillin for 7 days. After 1 day of penicillin therapy the patient was asymptomatic. Follow-up genital, rectal, nasopharyngeal, and blood cultures were negative for N. gonorrhoeae.
In April 1975, the patient was again admitted to the hospital with a 3-day history of fever with swelling and pain in her right elbow and right knee. Skin lesions typical of DGI were noted on a hand and a foot. A cervical culture was positive for N. gonorrhoeae, but blood cultures were negative. The patient had remarkable improvement with intravenous penicillin therapy.
The patient has had two episodes of documented DGI and a third episode of possible DGI. METHODS Sera. Human sera used in these studies were obtained from blood drawn by venipuncture. Sera used for complement assays were either freshly drawn or freshly frozen in aliquots at -70°C. Samples were discarded after thawing. Normal sera were obtained and stored in a similar manner. Complement donor serum (Cd) used in bactericidal assays was obtained from a 15-yr-old boy with familial hypogammaglobulinemia. He had no demonstrable antibodies to N. gonorrhoeae and a serum CH5o of 50 U. Sera from four normal persons were pooled and used as a reference serum in the hemolytic assays.
Guinea pig serum was obtained from Cordis Laboratories, Miami, Fla., stored in aliquots at -70'C, and discarded after thawing.
Specific antisera. Anti-human C3 and anti-human C4 antisera prepared in rabbits was obtained from Behring Diagnostics, Somerville, N. J. C3 proactivator (C3PA) levels were determined by single radial diffusion using plates obtained from Behring Diagnostics. Monospecific goat anti-human C8 antisera was provided by Dr. H. J. Mfiller-Eberhard, Scripps Clinic and Research Foundation, La Jolla, Calif. Rabbit antisera (hemolysin) to sheep erythrocytes was purchased from Grand Island Biological Co., Grand Island, N. Y.
Sheep red blood cells (SRBC). SRBC were obtained from Colorado Serum Co., Denver, Colo., preserved in modified Alserver's solution. Cells were used within 5 days of receipt. Before use cells were washed three times in 20 vol of 5 mM phosphate-buffered saline (PBS), pH 7.2-7.4.
Complement assays. Hemolytic whole complement assays (CH5o) were performed as described by Taliaferro and Taliaferro (7) with SRBC sensitized with hemolysin (EA). Individual complement component titers (Cl through 9) were determined by the procedures of Nelson et al. (8) with modifications suggested by Cordis Laboratories. Reaction tubes were prepared containing a final volume of 2.5 ml of reactants, incubated, and the percent lysis determined with a Coleman Jr. Spectrophotometer model 6/35 (Coleman Instruments Div., Perkin Elmer Corp., Oak Brook, Ill.) at 415 nm. The CHso titer was read as the reciprocal of the dilution giving 50%o lysis. Functionally pure complement components (C1-9) and cellular intermediates were obtained from Cordis Laboratories. Human or guinea pig serum used to reconstitute the deficient serum was diluted 1: 20 in glucose-gelatin Veronal buffer (Gl-GVB) containing 0.01 M EDTA (Calbiochem, La Jolla, Calif.); 2 ml of 1% EA was added to 1 ml of serum, the mixture incubated 20 min at 30'C and 1 ml of EDTA-treated serum added. After incubation at 370C for 30 min the degree of hemolysis was determined at a wave length of 541 nm in a Coleman Jr. Spectrophotometer.
Quantitative determination of C8 was done in the laboratory of Dr. H. J. Muller-Eberhard by single radial diffusion (9) with monospecific goat anti-human C8 antisera. Immunoelectrophoresis of normal and patient's serum was performed as described elsewhere (10) .
Activation of the alternate pathway. Serum samples were divided into two 0.5-ml aliquots and inulin (Difco Laboratories, Detroit, Mich.), 1 mg, was added to one aliquot. The samples were then incubated for 30 min at 370C and functional C3 and C4 titers were determined on both the inulin-treated and untreated samples.
Complement coating of red blood cells. Sensitized SRBC, 1 ml of a 1%o suspension, were incubated with 1 ml of CS- (11) . Polymorphonuclear leukocyte (PMN) suspensions were prepared as described by B6yum (12) .
Chemotaxis. The generation of chemotactic factors was studied by techniques similar to those as described by Leddy et al. (4) and Miller and Nilsson (11) with chambers described by Horwitz and Garrett (13) . Chemotactic factors were generated by mixing 1 vol of undiluted serum with 4 vol of heat-aggregated IgG (650C for 20 min), 1 mg/ml, and incubating the mixture at room temperature for 20 min. The lower chamber was then filled with the chemotactic factor and the upper chamber was filled with 0.5 ml of PMN suspension. The chamber was incubated at 370C for 90 min, the filter removed and stained and the average number of PMN per high-power field determined. Only PMN which had migrated through the filter were counted. A minimum of 10 fields were counted.
Coagulation studies. Activated partial thromboplastin time was performed as described by Davidsohn and Henry (14) . Activated clotting time was determined by the method of Hattersley (15) . Recalcification time was determined by the method described by Colman et al. (16) .
Isolation of N. gonorrhoeae. N. gonorrhoeae in the patient's blood culture were subcultured once on GCI agar (GC agar base [Bioquest, Oxnard, Calif.] with IsovitaleX
[Bioquest]) and incubated at 36.5 0C in a 5% CO2 incubator.
The organisms were then frozen at -70'C in small aliquots in a mixture of equal parts of MHB (Mueller-Hinton Broth [Bioquest]) and defibrinated calf serum (Grand Island Biological Co.). N. gonorrhoeae to be used for the bactericidal assays were grown for 16 h on GCI agar after inoculation from the frozen specimens or after subculture of type 1 gonococcal colonies (17) .
N. gonorrhoeae bactericidal assay. Serum bactericidal antibody activity was assayed in a buffered medium containing medium 199 (obtained 10 X concentrated, Microbiological Associates, Bethesda, Md.); 0.025 M N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid buffer, pH 7.4 (Microbiological Associates); and 0.5% bovine serum albumin (Miles Laboratories, Inc., Kankakee, Ill.). N. gonorrhoeae were gently taken from the agar surface, placed into the buffered medium, and adjusted to an OD of 0.12 (Coleman Jr. Spectrophotometer) which corresponded to 108 colony-forming units (CFU) per ml. The bactericidal reaction mixture contained: 0.1 ml of the N. gonorrhoeae inoculum, 0.1 ml of the patient's freshly frozen serum or heated serum (56°C, 30 min), 0.2 ml of Cd (10 CH50 U), and sufficient buffered medium to make a final volume of 1.0 ml. Cd containing 10 CH50 U, when added to heated serum, had previously been shown to reconstitute the serum gonococcal bactericidal activity.! In experiments using functionally pure C8 in place of Cd serum 10,000 U of C8 in 0.15 M NaCl was added to the reaction mixture with 2 X concentrated buffered medium, yielding a final concentration of buffered medium equivalent to the standard assay mixture. The bactericidal assay reaction mixtures were incubated at 37°C in snap-cap plastic tubes (Falcon Plastics Div., Bioquest) on a rotating rack (Fisher Scientific Co., Pittsburgh, Pa.) at 20 rpm. At appropriate intervals 0.1-ml samples were removed and serially diluted in MHB, plated on GCI agar, and incubated at 36.5°C overnight in 5%o C02 for CFU determinations.
Opsonization, phagocytosis, and killing of staphylococcus. The staphylococcus opsonization experiments were done with 'Brooks, G. F. Unpublished observations. modifications of the techniques of Klebanoff (18, 19) . Briefly, to prepare PMN 10-ml volumes of whole blood from normal donors were mixed with 10-ml volumes of 2% dextran 250 (Pharmacia Fine Chemicals, Piscataway, N. J.) in physiological saline, pH 7.4. After sedimentation of the red blood cells for 20 min the supernates were collected and the white blood cells gently pelleted (150 g, 10 min). The white cells were gently washed with 0.87%o ammonium chloride to lyse the remaining red cells, recentrifuged, mixed with calcium-free Krebs-Ringer phosphate buffer, and the percent and absolute number of PMN enumerated.
Staphylococcus aureus 502A was grown overnight on agar containing 5%o sheep blood. Growth from several colonies was transferred to MHB and growth was continued for 3 h in a shaker water bath (370C, 90 oscillations/min). The bacteria were sedimented by centrifugation, washed twice with sterile water, and resuspended in sterile water at a concentration of about 108 CFU per ml.
The complete reaction mixture contained about 107 CFU of staphylococcus 502A, 0. C3 and C4 was demonstrated by the agglutination of EA, after incubation with the patient's serum, with antisera monospecific for C3 and C4. These results indicated that the patient's serum contained functionally active C1 through C3 and was probably deficient in one of the later acting components. Heat-inactivated Cd serum failed to restore the bactericidal activity of the patient's serum. Analysis of the results suggested that the patient's serum might be deficient in the heat-labile component C8. The addition of 100 U of functionally pure C8, but not C9, restored the hemolytic activity of the patient's serum. Hemolysis of EA after the addition of C8 was dose related. The results of these assays expressed as a dose-response curve (Fig. 1) the C8-deficient patient and those in the pool of normal sera were determined simultaneously. The results are shown in Table I . With the exception of the absence of C8 and a lower level of C9, all of the complement components in the serum of the C8-deficient patient were normal. The absence of any functional C8 activity demonstrated that the lack of serum hemolytic complement activity could be attributed to this deficiency.
Analysis of the patient's serum by single radial diffusion with monospecific goat anti-C8 antisera did not produce any visible precipitin line. Normal serum used as a reference contains approximately 80 /Ag/ml of C8. After immunoelectrophoresis of the patient's serum, and normal serum, formation of a precipitin line with anti-C8 antisera was observed only with the normal serum.
The lack of C8 activity did not appear to be the result of the presence of an inhibitor. The CHbo activity (Table I ). The incubation of the patient's serum with inulin reduced the functional C3 CH60 titer in the patient's serum from 1,200 to 600 U and in the normal control from 850 to 410 U while no decrease in C4 titers were observed.
Bactericidal activity of C8-deficient serum. The patient's serum was not observed to possess any bactericidal activity against N. gonorrhoeae either after the initial subculture or after selective subculture of colony type 1 or 3 cells. However, the addition of Cd containing 10 CH60 U to the patient's freshly frozen serum or heated serum reconstituted the bactericidal activity (Fig. 2) . The reconstituted serum yielded a 10,000-fold or greater reduction in CFU regardless of the number of prior subcultures or N. gonorrhoeae colony type. Neither the patient's freshly frozen serum, heated serum, nor the Cd serum had any bactericidal activity. The addition of functionally pure C8, in a concentration equivalent to 100,000 U/ml of serum, to the patient's freshly frozen serum restored serum bactericidal activity (Fig.  3) . Addition of functionally pure complement components C2-7 did not reconstitute serum bactericidal activity.
Opsonization. FIGuRE 3 Restoration of bactericidal activity in C8-deficient serum (S) after the addition of purified C8 (C8) or Cd.
( Table II ). The phagocytosis of N. gonorrhoeae by PMN was enhanced by the patient's serum (21) . This activity was lost after heat inactivation (560C for 30 min) of the patient's serum.
Opsonization, phagocytosis, and killing of staphylococcus 502A. The patient's serum yielded opsonization with resultant phagocytosis and killing of the test staphylococcus (Fig. 4) . The results were similiar to those obtained with the normal, AB, Rh-positive serum, much as previously reported (19 chemotactic substances was similar to that observed with normal serum. The results are summarized in Table III . Coagulation studies. The kaolin-activated clotting time and activated partial prothrombin clotting time were normal. The recalcification time of plasma collected in siliconized glassware showed a significant shortening. After contact with kaolin the n-tosyl-L-arginine methyl esterase activity generated was within normal limits. These findings provided evidence that contact activation of the intrinsic pathway of blood coagulation as well as generation of kallikrein mediated by activated Hageman factor were intact in the C8-deficient patient.
Family studies. The family pedigree is shown in Fig.  5 . The CHM0, C8 functional titers, and C8 levels determined by radial diffusion are listed in Table IV . The proband (II-2) lacks C8 while her parents (I-1, 2) and children (III-1, 2) have about one-half normal levels of C8. There was no known consanguineous marriage in the three generations preceeding the proband.~5 
DISCUSSION
The presence of hereditory deficiencies in the complement system of man has provided opportunities to better evaluate the role of complement in vivo. In this paper we have presented evidence of the discovery of a patient with a deficiency of the eighth component of complement. The patient's serum has no detectable functionally active or immunologically reactive C8. Activation of complement components Cl through C7 via the classical pathway or through alternate pathway activation of C3 is a complex process with multiple biologically functional interrelationships (22) . The absence of C8 does not appear to modify most of these biological effects as evidenced by normal activation in our patient's serum of the classical and alternate pathways, generation of opsonic and chemotactic activity, and normal coagulation. It appears from these studies that the key, if not only, role of C8 in man is the production of complement-mediated membrane damage; only a few molecules of C8 are required for red cell lysis (23) .
The absence of C8 in the proband's serum indicates she is homozygous for C8 deficiency since approximately half-normal C8 levels are present in her parents' and children's sera, demonstrating that they are obligate heterozygotes (Fig. 5) . The fathers of the proband's children are presumed to be homozygous for the normal C8 alleles. These results are consistent with the interpretation that C8 deficiency is genetically transmitted as part of the autosomal codominant system. We suggest that the locus be named "C&." Then the homozygous deficiency phenotype would be designated "C8 BB," the heterozygous phenotype "C8 AB," and the normal homozygous phenotype "C8 AA."
Deficiencies in the earlier acting components, Cl through C5, and in the inhibitors of the human comple- (32, 33) . Certainly, a functional serum meningococcal bactericidal antibody system is important in protection against N. meningitidis bacteremia and meningitis (32) . It is likely that a similar mechanism exists for protection against N. gonorrhoeae bacteremia.
We have learned of five patients with deficiencies or abnormalities of the later acting components of complement. Neither of the C7-deficient persons had repeated severe infections (5, 6) . A woman with C6 deficiency had two documented episodes of DGI but no history of other recurrent infections. A child with C6 deficiency had repeated episodes of N. meningitidis infections.' Our patient with C8 deficiency has had two, possibly three, episodes of DGI.
The association of bacteremic Neisseria infections, C6, C8, or bactericidal antibody deficiencies is very strong (4, 32, 33) . While there is no definitive information on the importance of an intact complement or bactericidal antibody system in protection against N. gonorrhoeae bacteremia the two known sexually-active adults with C6 or C8 deficiency had repeated gonococcal bacteremia. The 6-yr-old child with C6 deficiency had repeated N. meningitidis bacteremia and probably had not been exposed to N. gonorrhoeae. DGI can mimic diseases such as rheumatoid arthritis or systemic lupus erythematosis, where physicians might frequently request complement evaluations. Regardless, the finding of patients with complement or antibody deficiency, nonfunctional bactericidal systems, and bacteremic Neisseria infections indicates that serum bactericidal function is important in protection against N. meningitidis and N. gonorrhoeae bacteremia.
A possible role for opsonic antibodies in protection against DGI is not clear. The importance of N. gonorrhoeae pili or other gonococcal cell surface antiphagocytic substances has yet to be clarified (34) (35) (36) (37) (38) . Regardless, opsonization with phagocytosis may be of secondary importance compared to protective serum bactericidal mechanisms. Our patient had a positive blood culture for N. gonorrhoeae after 3J wk of DGI syndrome. It is very unusual for DGI patients to have positive blood cultures after the first 2 or 3 days of illness (39) . Further, serum from her blood specimen which was culture positive for N. gonorrhoeae had opsonic activity, but her bactericidal system was not functional and she had a positive blood culture-again highlighting the importance of a bactericidal mechanism in protection against DGI.
In summary, the results of these studies suggest the major if not singular role of C8 in the human complement system is to promote complement-associated membrane damage. It appears this lytic activity may be important for adequate host resistance to infection by organisms of the genus Neisseria.
